Be Aware of Other Medications or Lifestyle Choices Before attributing every stomach upset to the GLP-1 medication, take a broader perspective
Novel pharmacological approaches Besides behavioral strategies, emerging pharmacologic agents, comprising anabolic and anti-catabolic drugs, have been demonstrated to be effective in the prevention and treatment of sarcopenia or disproportionate lean mass loss in patients receiving GLP-1RAs
Semaglutide and liraglutide have received FDA approval specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Antioxidant support Helps protect against environmental stressors
Let me know if you have any further questions or requests!
Carnitine deficiency and insufficiency cause various symptoms such as erythropoiesis-stimulating agent (ESA)-resistant anemia, muscle symptoms such as severe muscle cramps and asthenia, cardiac hypertrophy, arrhythmias, cardiac disfunctions, and increased inflammation, malnutrition, and sarcopenia